Alvotech

NASDAQ: ALVO
Share price (12/23/24): $12.52
Market cap (12/23/24): $3.780 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 06/15/22 FY 2022

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Registration withdrawal request

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Aztiq Pharma Partners S.a r.l.

Oaktree Acquisition Holdings II, L.P.

Oaktree Acquisition Holdings II, L.P.

Celtic Holdings SCA

News Filter

Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Reports Financial Results for the First Nine Months of 2024

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi®

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (Ustekinumab-Aekn), Expanding Its Label to Include Further Indications Approved for Reference Product, Stelara®

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC